Main
>
ONCOLOGY (**)
>
Breast Cancer>HER2+>MET ***
>
Treatment
>
UK. M. BioSimilar TrastuzuMAb
>
(*) USA Approval Date: 2017. 12.01
(*) USA Approval Date: 2017. 12.01's products
This section has no products